The exercise period for warrants of series TO 5 B begins today
Lund, Sweden – Today is the first day of the exercise period for Clinical Laserthermia Systems AB’s ("CLS" or the "Company") warrants of series TO 5 B, which were issued in connection with the Company's rights issue of units that was announced on 10 August 2022. Holders of warrants of series TO 5 B have, for each warrant, the right to subscribe for one (1) new B-share in CLS at a price of SEK 0.46 per share. The exercise period runs until and including 28 February 2023.Information about warrants of series TO 5 B In connection with the Company's rights issue of units that was announced on